Patou Gary's Form 4/A amendment
AmendedXenon Pharmaceuticals Inc. (XENE) · filed Dec 15, 2023
- Accession no.
- 0000950170-23-070912
- Filed
- Dec 15, 2023
- Trade date
- Dec 14, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
- Original filed
- Dec 15, 2023
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $311.9K. It was filed 1 day after the trade.
This amendment replaces 0000950170-23-070841 (filed Dec 15, 2023).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Patou GaryCIK 0001283535 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 14, 2023 | Common Shares | SSaleDisposed | −7,598 | $41.05 | −$311,897.9 | 4,902 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.